Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID-19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States

Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID-19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States

Background: Studies have shown conflicting results on the efficacy of tocilizumab (TCZ) for patients with COVID-19, with many confounders of clinical status and limited duration of the observation. Here, we evaluate the real-world long-term efficacy of TCZ in COVID-19 patients. Methods: We conducted...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Masayuki Nigo, Laila Rasmy, Sarah B. May, Aishwarya Rao, Sam Karimaghaei, Bijun Sai Kannadath, Alejandro De la Hoz, Cesar A. Arias, Liang Li, Degui Zhi
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Tocilizumab
COVID-19
De-identified Database
Infectious and parasitic diseases
RC109-216
Accès en ligne:https://doaj.org/article/b999958492c148f98c3cedd11fa10a1c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b999958492c148f98c3cedd11fa10a1c

Documents similaires